Further data mining demonstrated significantly higher MEF2D level in COPD patients with NSCLC than that in smokers, patients with COPD and no NSCLC, or patients with NSCLC and no COPD, compared with healthy non-smokers (Fig. 1d, p < 0.001). The gene discussed is MEF2D; the disease is chronic obstructive pulmonary disease.